FDA Approves Pembrolizumab for Treatment of PMBCL

FDA Approves Pembrolizumab for Advanced Cervical Cancer

FDA Approves Venetoclax for CLL, Small Lymphocytic Lymphoma

On June 8, 2018, the Food and Drug Administration (FDA) granted regular approval to venetoclax (Venclexta, AbbVie Inc. and Genentech Inc.) for patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL), with or without 17p deletion, who have received at least one prior therapy.

Read the full FDA announcement here.

Posted 6/11/2018

Pfizer’s Biosimilar RETACRIT® (epoetin alfa-epbx) Approved by U.S. FDA

CMS Begins Mailing Out New Medicare Cards

The Centers for Medicare & Medicaid Services (CMS) has begun mailing its newly-designed Medicare cards with new Medicare Beneficiary Identifiers to newly eligible and current Medicare beneficiaries. Cards will be sent out on a rolling basis throughout 2018 to fulfill the CMS requirement to remove Social Security Numbers from all Medicare cards by April 2019.

CMS will host a special Open Door Forum on April 5, 12:30 – 1:30 PM EST, to share updates about the new Medicare card mailing, information on how people with Medicare can look up their new Medicare card number or print a replacement card, and updates on resources for partners. To participate, visit https://webinar.cms.hhs.gov/r51uia09fgq/ and use the following information:

• Dial-In Number: 1-800-837-1935
• Conference ID #: 7065199

Check cms.gov/newcard often for the most up-to-date information.

Posted 4/4/2018

IMBRUVICA® Approved in New Formulation as One Pill, Once Daily

Trump Administration Announces MyHealthEData Initiative